A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

K. A. Papp, K. Reich, C. Paul, A. Blauvelt, W. Baran, C. Bolduc, D. Toth, R. G. Langley, J. Cather, A. B. Gottlieb, D. Thaçi, J. G. Krueger, C. B. Russell, C. E. Milmont, J. Li, P. A. Klekotka, G. Kricorian, A. Nirula